Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2005

01-06-2005 | Poster Presentation

Determining the factors affecting breast cancer infectivity by oncolytic adenovirus

Authors: C Mysinger, C Soria, J Yeh, C O'Shea, L Timmerman, F McCormick

Published in: Breast Cancer Research | Special Issue 2/2005

Login to get access

Excerpt

Cancer is the second leading cause of death in the United States. Traditional treatments for cancer, such as radiation and chemotherapy, are frequently ineffective and are often associated with painful side effects that diminish the quality of life for patients. New strategies for the treatment of cancer are greatly needed. Oncolytic viruses represent a new class of anticancer agents with the potential to greatly improve cancer treatment. …
Literature
1.
Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A, McCormick F: An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science. 1996, 274: 373-376. 10.1126/science.274.5286.373.CrossRefPubMed
Metadata
Title
Determining the factors affecting breast cancer infectivity by oncolytic adenovirus
Authors
C Mysinger
C Soria
J Yeh
C O'Shea
L Timmerman
F McCormick
Publication date
01-06-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1192

Other articles of this Special Issue 2/2005

Breast Cancer Research 2/2005 Go to the issue

Poster Presentation

Potentiated phospho-protein networks in cancer cells

Poster Presentation

Hypoxia promotes invasion and metastasis of breast cancer cells by increasing lysyl oxidase expression

Oral Presentation

Molecular profiling of early breast cancer in relation to detection of micrometastases and outcome

Poster Presentation

Identification of drug targets for the treatment of Basal-like tumors

Poster Presentation

Breast tumors induced by high-dose radiation display similar genetic profiles

Poster Presentation

Cancer gene mutation discovery and detection using array-based resequencing
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits